B. Salisbury

发表

Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.

A. Wilde, Jamie D. Kapplinger, D. Tester, 2009, Heart rhythm.

The structure of common genetic variation in United States populations.

J. Stephens, M. Bamshad, B. Salisbury, 2007, American journal of human genetics.

Ancestral state estimation and taxon sampling density.

B. Salisbury, J. Kim, 2001, Systematic biology.

Prevalence of early-onset atrial fibrillation in congenital long QT syndrome.

Michael J Ackerman, C. Reed, D. Tester, 2008, Heart rhythm.

Candidate-Gene Association Study of Mothers with Pre-Eclampsia, and Their Infants, Analyzing 775 SNPs in 190 Genes

G. Vovis, K. Goddard, Qing Lu, 2006, Human Heredity.

Pharmacogenetic Issues in Thorough QT Trials

R. Judson, C. Reed, B. Salisbury, 2012, Molecular Diagnosis & Therapy.

Polymorphisms in maternal and fetal genes encoding for proteins involved in extracellular matrix metabolism alter the risk for small-for-gestational-age

Scott M. Williams, G. Vovis, B. Salisbury, 2011, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes.

Scott M. Williams, G. Vovis, B. Salisbury, 2009, American journal of obstetrics and gynecology.

A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM).

Scott M. Williams, G. Vovis, B. Salisbury, 2010, American journal of obstetrics and gynecology.

The Use of Non-Variant Sites to Improve the Clinical Assessment of Whole-Genome Sequence Data

J. M. Harvey, F. Griggio, C. Franceschi, 2015, PloS one.

Strongest Evidence: Maximum Apparent Phylogenetic Signal as a New Cladistic Optimality Criterion

B. Salisbury, 1999, Cladistics : the international journal of the Willi Hennig Society.

Strongest Evidence: Maximum Apparent Phylogenetic Signal as a New Cladistic Optimality Criterion☆

B. Salisbury, 1999 .

Ancestral state estimation and taxon sampling density.

B. Salisbury, J. Kim, Junhyong Kim, 2001, Systematic biology.

Expression of a Common LQT1 Mutation in Five Apparently Unrelated Families in a Regional Inherited Arrhythmia Clinic

A. Skanes, A. Krahn, G. Klein, 2010, Journal of cardiovascular electrophysiology.

Enhancing the Predictive Power of Mutations in the C-Terminus of the KCNQ1-Encoded Kv7.1 Voltage-Gated Potassium Channel

T. Callis, A. Wilde, Jamie D. Kapplinger, 2015, Journal of Cardiovascular Translational Research.

AB47-4: The single nucleotide polymorphism D85N-KCNE1 is associated with both congenital and drug-induced Long QT

R. Judson, A. Moss, W. Zareba, 2006 .

ANALYTICAL VALIDATION OF A COMPUTATIONAL METHOD FOR PHARMACOGENETIC GENOTYPING FROM CLINICAL WHOLE EXOME SEQUENCING.

S. C. Sahinalp, Ibrahim Numanagić, B. Salisbury, 2022, The Journal of molecular diagnostics : JMD.

SNP and haplotype variation in the human genome.

J. Stephens, B. Salisbury, M. Pungliya, 2003, Mutation research.

Distinguishing Hypertrophic Cardiomyopathy-Associated Mutations from Background Genetic Noise

Michael J Ackerman, T. Callis, Jamie D. Kapplinger, 2014, Journal of Cardiovascular Translational Research.

An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.

J. Towbin, J. Brugada, R. Brugada, 2010, Heart rhythm.

How many SNPs does a genome-wide haplotype map require?

Richard Judson, Andreas Windemuth, J. Stephens, 2002, Pharmacogenomics.

Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise.

R. Hauer, H. Calkins, T. Callis, 2011, Journal of the American College of Cardiology.

Phylogenetic and Physicochemical Analyses Enhance the Classification of Rare Nonsynonymous Single Nucleotide Variants in Type 1 and 2 Long-QT Syndrome

Michael J Ackerman, Marielle Alders, A. Wilde, 2012, Circulation. Cardiovascular genetics.

Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false-negative results.

R. Judson, D. Tester, B. Salisbury, 2005, Heart rhythm.

Deconstructing the relationship between genetics and race

Michael Bamshad, Benjamin A. Salisbury, J. Stephens, 2004, Nature Reviews Genetics.

Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation.

A. Wilde, D. Tester, B. Salisbury, 2010, Heart rhythm.

Genetic Testing for Long-QT Syndrome: Distinguishing Pathogenic Mutations From Benign Variants

Michael J Ackerman, Suraj Kapa, Marielle Alders, 2009, Circulation.

DNA variability of human genes

Julie A Schneider, J. Stephens, B. Salisbury, 2003, Mechanisms of Ageing and Development.

Genetic variability and evolution of two pharmacologically important classes of genes.

J. Stephens, K. Nandabalan, B. Salisbury, 2004, Pharmacogenomics.

Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.

A. Malhotra, M. Athanasiou, T. Lencz, 2011, The Journal of clinical psychiatry.

The SLCO1B1*5 genetic variant is associated with statin-induced side effects.

G. Ginsburg, D. Voora, C. Reed, 2009, Journal of the American College of Cardiology.

Pharmacogenetic Predictors of Statin-Mediated Low-Density Lipoprotein Cholesterol Reduction and Dose Response

G. Ginsburg, D. Voora, C. Reed, 2008, Circulation. Cardiovascular genetics.

Retention, Fasting Patterns, and Weight Loss With an Intermittent Fasting App: Large-Scale, 52-Week Observational Study

B. Salisbury, Joy L. Lee, Shelagh A Fraser, 2022, JMIR mHealth and uHealth.

Retention, Fasting Patterns, and Weight Loss With an Intermittent Fasting App: A Large-scale, 52-week Observational Study (Preprint)

B. Salisbury, Joy L. Lee, Shelagh A Fraser, 2021, JMIR mHealth and uHealth.

Computational pharmacogenotype extraction from clinical next-generation sequencing

S. C. Sahinalp, Ibrahim Numanagić, B. Salisbury, 2023, Frontiers in oncology.

Misinformative characters and phylogeny shape.

B. Salisbury, 1999, Systematic biology.

A Tree Obscured By Vines: Horizontal Gene Transfer and the Median Tree Method of Estimating Species Phylogeny

Junhyong Kim, Benjamin A. Salisbury, Junhyong Kim, 2000, Pacific Symposium on Biocomputing.

Pharmacogenetic Predictors of Statin-Mediated Low-Density Lipoprotein Cholesterol Reduction and Dose Response

G. Ginsburg, D. Voora, C. Reed, 2008, Circulation. Cardiovascular genetics.